Heartflow, Inc. Common Stock is a publicly traded company on NASDAQ, with a market cap of $2.5B. As of Q3 2025, 53% of shares are held by 87 institutional investors, with Bain Capital Life Sciences Investors, LLC as the largest holder at 14.93%.
Overview of institutional ownership in HTFL as of Q3 2025 with a market cap of $2.8B
Based on market cap of $2.8B as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in HTFL as of Q3 2025
| Institution | Position Value |
|---|---|
B Bain Capital Life Sciences Investors, LLC Institution | $419.0M 27.84% of portfolio |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | $164.3M 0.03% of portfolio |
FMR LLC Institution | $159.2M 0.01% of portfolio |
B BAILLIE GIFFORD & CO Institution | $101.2M 0.08% of portfolio |
S Schusterman Interests, LLC Institution | $65.3M 14.92% of portfolio |
VANGUARD GROUP INC Institution | $48.9M 0.00% of portfolio |
C Capital International Investors Institution | $43.7M 0.01% of portfolio |
BAMCO INC /NY/ Long Only Manager | $41.7M 0.11% of portfolio |
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | $40.9M 0.00% of portfolio |
LORD, ABBETT & CO. LLC Long Only Manager | $38.1M 0.12% of portfolio |
Institutional buying and selling activity for HTFL in Q3 2025
| Institution | Net Bought | |
|---|---|---|
| No buyers found | ||
| Institution | Net Sold | |
|---|---|---|
| No sellers found | ||
Institutions that initiated new positions or completely exited HTFL in Q3 2025
| Institution | Position Value |
|---|---|
B Bain Capital Life Sciences Investors, LLC Institution | $419.0M 12.4M shares |
WELLINGTON MANAGEMENT CO LLP Long Only Manager | $164.3M 4.9M shares |
FMR LLC Institution | $159.2M 4.7M shares |
B BAILLIE GIFFORD & CO Institution | $101.2M 3.0M shares |
S Schusterman Interests, LLC Institution | $65.3M 1.9M shares |
VANGUARD GROUP INC Institution | $48.9M 1.5M shares |
C Capital International Investors Institution | $43.7M 1.3M shares |
BAMCO INC /NY/ Long Only Manager | $41.7M 1.2M shares |
PRICE T ROWE ASSOCIATES INC /MD/ Long Only Manager | $40.9M 1.2M shares |
LORD, ABBETT & CO. LLC Long Only Manager | $38.1M 1.1M shares |
| Institution | Previous Position |
|---|---|
| No exited positions found | |
Institutions with the largest Call and Put options positions in HTFL as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with HTFL as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
B Bain Capital Life Sciences Investors, LLC Institution | 27.84% $419.0M |
S Schusterman Interests, LLC Institution | 14.92% $65.3M |
1.24% $10.5M | |
XXEC, Inc. RIA/Wealth | 0.92% $1.0M |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC Hedge Fund•Long/Short | 0.91% $28.6M |
Sandia Investment Management LP Hedge Fund•Event Driven | 0.86% $252.5K |
BRANDYWINE MANAGERS, LLC Fund of Funds | 0.54% $564.6K |
Rock Springs Capital Management LP Hedge Fund•Sector | 0.49% $8.4M |
AH Lisanti Capital Growth, LLC Long Only Manager | 0.24% $981.7K |
EMERALD ADVISERS INC/PA Long Only Manager | 0.24% $7.3M |
Discover hedge funds investing in HTFL

| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $1.6B | 25.79% | |
Medical - Healthcare Plans Healthcare | $322.8M | 5.35% | |
Biotechnology Healthcare | $286.9M | 4.75% |
We use cookies for analytics. See our Privacy and Cookie Policy.